CSPC Pharmaceutical Group Ltd (CHJTF)
0.85
+0.10
(+13.33%)
USD |
OTCM |
May 17, 16:00
CSPC Pharmaceutical Group Total Assets (Quarterly): 6.529B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.529B |
| June 30, 2023 | 6.021B |
| June 30, 2023 | 6.021B |
| December 31, 2022 | 6.054B |
| June 30, 2022 | 5.795B |
| December 31, 2021 | 5.450B |
| June 30, 2021 | 5.081B |
| June 30, 2021 | 5.081B |
| December 31, 2020 | 4.603B |
| June 30, 2020 | 4.113B |
| June 30, 2020 | 4.113B |
| December 31, 2019 | 3.761B |
| June 30, 2019 | 3.531B |
| June 30, 2019 | 3.531B |
| December 31, 2018 | 3.375B |
| June 30, 2018 | 3.296B |
| June 30, 2018 | 3.296B |
| December 31, 2017 | 2.755B |
| June 30, 2017 | 2.139B |
| June 30, 2017 | 2.139B |
| Date | Value |
|---|---|
| December 31, 2016 | 1.903B |
| June 30, 2016 | 1.825B |
| June 30, 2016 | 1.825B |
| December 31, 2015 | 1.747B |
| June 30, 2015 | 1.765B |
| June 30, 2015 | 1.765B |
| December 31, 2014 | 1.612B |
| June 30, 2014 | 1.567B |
| June 30, 2014 | 1.567B |
| December 31, 2013 | 1.573B |
| June 30, 2013 | 1.644B |
| June 30, 2013 | 1.644B |
| December 31, 2012 | 1.767B |
| June 30, 2012 | 1.331B |
| December 31, 2011 | 308.04M |
| June 30, 2011 | 1.322B |
| December 31, 2010 | 224.32M |
| June 30, 2010 | 1.178B |
| December 31, 2009 | 1.155B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.531B
Minimum
Jun 2019
6.529B
Maximum
Dec 2023
4.978B
Average
5.081B
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 13.66B |
| CASI Pharmaceuticals Inc | 75.27M |
| Zai Lab Ltd | 988.44M |
| Gracell Biotechnologies Inc (DELISTED) | 259.03M |
| Adagene Inc | 115.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.589B |
| Shareholders Equity (Quarterly) | 4.684B |
| Debt to Equity Ratio | 0.0136 |
| Current Ratio | 2.626 |
| Net Debt Paydown Yield | -0.13% |